Join to View Full Profile
78 Baker StProvidence, RI 02905
Phone+1 401-781-2400
Fax+1 401-781-2687
Dr. Emgushov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rinchen-Tzo Emgushov is an experienced physician specializing in Internal Medicine with a sub-specialty in Infectious Disease. Based in Providence, RI, she completed her medical education at the Lewis Katz School of Medicine at Temple University. Dr. Emgushov spent her residency and fellowship at Roger Williams Medical Center. She has contributed to the medical field with publications on varied topics like HIV and infectious diseases. Notably, Dr. Emgushov has earned various honors, including the Regional Top Doctor from Castle Connolly in 2014 and certifications and recognition from eClinicalWorks EHR and the National Committee for Quality Assurance from 2011 to 2013.
Education & Training
Roger Williams Medical CenterFellowship, Infectious Disease, 1989 - 1991- Roger Williams Medical CenterResidency, Internal Medicine, 1986 - 1989
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Obstetrics and Gynecology, 1985 - 1986
Lewis Katz School of Medicine at Temple UniversityClass of 1985
Certifications & Licensure
RI State Medical License 1991 - 2026
PA State Medical License 1991 - 1994
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2011, 2013-2016
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2011, 2013-2016
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 1 citationsFactitious HIV syndrome in young women.Mileno, Barnowski C, Fiore T, Gormley J, Josiah D. Rich
The AIDS Reader. 2001-05-01 - 24 citationsA phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects.Robert C. Kalayjian, Gail Skowron, Rinchen Tzo Emgushov, Michael Chance, Sharon A. Spell
Journal of Acquired Immune Deficiency Syndromes. 1994-04-01 - 1 citationsRecent advances in infectious diseases.R T Emgushov, Steven M. Opal
Rhode Island Medical Journal. 1990-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
